JP2022060182A5 - - Google Patents

Download PDF

Info

Publication number
JP2022060182A5
JP2022060182A5 JP2021162451A JP2021162451A JP2022060182A5 JP 2022060182 A5 JP2022060182 A5 JP 2022060182A5 JP 2021162451 A JP2021162451 A JP 2021162451A JP 2021162451 A JP2021162451 A JP 2021162451A JP 2022060182 A5 JP2022060182 A5 JP 2022060182A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
specifically binds
arm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021162451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022060182A (ja
JP7714992B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2022060182A publication Critical patent/JP2022060182A/ja
Publication of JP2022060182A5 publication Critical patent/JP2022060182A5/ja
Application granted granted Critical
Publication of JP7714992B2 publication Critical patent/JP7714992B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021162451A 2020-10-02 2021-10-01 二重特異性抗体を有効成分として含む医薬組成物 Active JP7714992B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020167384 2020-10-02
JP2020167384 2020-10-02

Publications (3)

Publication Number Publication Date
JP2022060182A JP2022060182A (ja) 2022-04-14
JP2022060182A5 true JP2022060182A5 (enExample) 2024-01-24
JP7714992B2 JP7714992B2 (ja) 2025-07-30

Family

ID=81124684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021162451A Active JP7714992B2 (ja) 2020-10-02 2021-10-01 二重特異性抗体を有効成分として含む医薬組成物

Country Status (1)

Country Link
JP (1) JP7714992B2 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008537941A (ja) 2005-03-31 2008-10-02 ゼンコー・インコーポレイテッド 最適化特性を有するＦｃ変異体
WO2008092117A2 (en) 2007-01-25 2008-07-31 Xencor, Inc. Immunoglobulins with modifications in the fcr binding region
ES2687808T3 (es) 2007-09-26 2018-10-29 Chugai Seiyaku Kabushiki Kaisha Región constante de anticuerpo modificado
RU2559524C2 (ru) 2008-06-27 2015-08-10 Мерюс Б.В. Продуцирующие антитела млекопитающие, не являющиеся человеком
BR112018008068A2 (en) 2015-10-23 2018-11-13 Merus N.V. binding molecules that inhibit cancer growth
CN106939050B (zh) 2017-03-27 2019-05-10 顺昊细胞生物技术（天津）股份有限公司 抗pd1和cd19双特异性抗体及其应用
CN119119284A (zh) 2017-07-06 2024-12-13 美勒斯公司 调节由细胞表达的生物活性的结合分子

Similar Documents

Publication Publication Date Title
AU2008232902B2 (en) Antibody formulation
JP6844719B2 (ja) 二重特異性抗体
JP7476997B2 (ja) 二重特異性抗体
JP7688805B2 (ja) 二重特異性抗体
US20110256149A1 (en) Antibody formulation
JP2021075580A5 (enExample)
JP7574692B2 (ja) 二重特異性抗体
JP2022060182A5 (enExample)
NZ761547B2 (en) Bispecific antibody
RU2021128262A (ru) Биспецифическое антитело
JP7714992B2 (ja) 二重特異性抗体を有効成分として含む医薬組成物
RU2814713C2 (ru) Биспецифическое антитело
HK40062297A (en) Bispecific antibody
HK40062297B (zh) 双特异性抗体
NZ780860B2 (en) Bispecific antibody
HK40036202A (en) Bispecific antibody
HK40036202B (zh) 双特异性抗体